Add like
Add dislike
Add to saved papers

Achieving Low-Energy Driven Viologens-Based Electrochromic Devices Utilizing Polymeric Ionic Liquids.

Herein, three kinds of viologens-based electrochromic devices (ECDs) (heptyl viologen (HV(BF4 )2 ), octyl viologen (OV(BF4 )2 ), and nonyl viologen (NV(BF4 )2 )) were fabricated utilizing ferrocene (Fc) as a redox mediator. Among them, the NV(BF4 )2 -based ECD exhibits the highest coloration efficiency (36.2 cm2 /C) owing to the lowest driving energy. Besides, switching between 0 and 1.2 V, the NV(BF4 )2 -based ECD shows a desirable initial transmittance change (ΔT = 56.7% at 605 nm), and long-term stability (ΔT = 45.4% after 4000 cycles). Furthermore, a UV-cured polymer electrolyte containing polymeric ionic liquid (PIL, 1-allyl-3-methylimidazolium bis(trifluoromethylsulfonyl)imide) and ethoxylated trimethylolpropane triacrylate (ETPTA) was introduced to the NV(BF4 )2 -based ECD. By controlling the weight percentage of the PIL, different curing degrees of the polymer electrolytes were obtained and led to an improved stability of the NV(BF4 )2 -based ECD because of the immobilization of NV(BF4 )2 . This observation was explained by calculating the apparent diffusivity (Dapp ) of the redox species in the NV(BF4 )2 -based ECD under various curing degrees. In addition, increasing the amount of PIL leads to a lower driven energy needed for the NV(BF4 )2 -based ECD, following the same trend as the value of Dapp . Among all NV(BF4 )2 -based ECDs, 20 wt % of PIL addition (20-PIL ECD) exhibits large transmittance change (ΔT = 55.2% at 605 nm), short switching times (2.13 s in coloring and 2.10 s in bleaching), high coloration efficiency (60.4 and 273.5 cm2 /C at 605 nm, after excluding the current density at the steady state), and exceptional cycling stability (ΔT = 53.8% after 10,000 cycles, or retained 97.5% of its initial ΔT).

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app